Theralase launches laser sales team dedicated to horse industry

November 20, 2010 — Theralase Technologies Inc. (TSX-V: TLT) has launched a laser sales team dedicated to the sales of the company’s products to the horse industry.

The Theralase sales team will supply therapeutic medical laser technology to veterinarians, horse owners, and trainers that is able to reduce pain and inflammation, while stimulating the growth of new tissue, substantially speeding the return of their equine athletes to top performance.

To accomplish this, Theralase has added an experienced sales team to service the horse industry, including Doug Nash and David Groves. Nash has more than 30 years of hands-on experience in the standardbred industry and is an instructor teaching courses through Equine Guelph and the REACH campus at the University of Guelph.

Groves, president, Equine World Sales Division has been with Theralase for five years and has more than 20 years experience in the North American healthcare market successfully launching healthcare products.

Nash stated, “My involvement with Theralase stems from the positive results I have witnessed firsthand with the technology in the alleviation of pain and inflammation and the promotion of healing. I am delighted results of the Theralase technology have proven to be both safe and highly effective for treating a wide range of neural muscular skeletal treatments in horses, including acupuncture, using predetermined protocols.”

Groves stated, “We have consistently demonstrated superior patient outcomes in the human market by accelerating the healing process; therefore, it was a natural extension of proven clinical outcomes applied to the equine athlete. Based on the equine results to date, we can confidently offer a pain-free and non-invasive modality to treat common pain and inflammatory conditions in the thoroughbred, standardbred and championship equine markets.”

Dr. Terry Ruch a member of the Theralase Medical and Scientific Advisory Board stated, “I am glad to see Theralase expand their presence in the equine market. The Theralase is able to increase efficacy, provide superior clinical outcomes and allow for faster return to competition for many equine athletes. The Theralase works extremely well at reducing pain and inflammation, working on numerous soft tissue injuries, such as: muscles, tendons and ligaments.”

Roger Dumoulin-White, president and CEO of Theralase Inc. stated, “The Company is delighted to have two seasoned professionals, Doug and David, to head up our equine sales team, utilizing the vast knowledge of equine soft tissue injuries that Dr. Ruch possesses. All members bring decades of hands-on experience to the table, which will ultimately benefit the Company in both expanded knowledge of the horse industry and increased revenue.”

Source: Theralase Inc., www.theralase.com